SPEV
Price
$0.02
Change
-$0.02 (-50.00%)
Updated
Dec 17 closing price
UCAR
Price
$6.65
Change
-$0.50 (-6.99%)
Updated
Dec 18 closing price
Ad is loading...

SPEV vs UCAR

Header iconSPEV vs UCAR Comparison
Open Charts SPEV vs UCARBanner chart's image
Shorepower Technologies
Price$0.02
Change-$0.02 (-50.00%)
Volume$230K
CapitalizationN/A
U Power
Price$6.65
Change-$0.50 (-6.99%)
Volume$7.42K
CapitalizationN/A
SPEV vs UCAR Comparison Chart
Loading...
SPEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SPEV vs. UCAR commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPEV is a Hold and UCAR is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SPEV: $0.02 vs. UCAR: $6.65)
Brand notoriety: SPEV and UCAR are both not notable
Both companies represent the Specialty Stores industry
Current volume relative to the 65-day Moving Average: SPEV: 572% vs. UCAR: 30%
Market capitalization -- SPEV: $9.35M vs. UCAR: $3.89M
SPEV [@Specialty Stores] is valued at $9.35M. UCAR’s [@Specialty Stores] market capitalization is $3.89M. The market cap for tickers in the [@Specialty Stores] industry ranges from $380.15B to $0. The average market capitalization across the [@Specialty Stores] industry is $8.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPEV’s FA Score shows that 0 FA rating(s) are green whileUCAR’s FA Score has 0 green FA rating(s).

  • SPEV’s FA Score: 0 green, 5 red.
  • UCAR’s FA Score: 0 green, 5 red.
According to our system of comparison, UCAR is a better buy in the long-term than SPEV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPEV’s TA Score shows that 3 TA indicator(s) are bullish while UCAR’s TA Score has 5 bullish TA indicator(s).

  • SPEV’s TA Score: 3 bullish, 7 bearish.
  • UCAR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, UCAR is a better buy in the short-term than SPEV.

Price Growth

SPEV (@Specialty Stores) experienced а -48.89% price change this week, while UCAR (@Specialty Stores) price change was -11.10% for the same time period.

The average weekly price growth across all stocks in the @Specialty Stores industry was -5.55%. For the same industry, the average monthly price growth was -0.49%, and the average quarterly price growth was +2.16%.

Reported Earning Dates

SPEV is expected to report earnings on Jan 09, 2023.

Industries' Descriptions

@Specialty Stores (-5.55% weekly)

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPEV($9.35M) has a higher market cap than UCAR($3.89M). UCAR YTD gains are higher at: -63.760 vs. SPEV (-67.143).
SPEVUCARSPEV / UCAR
Capitalization9.35M3.89M240%
EBITDA-594.7KN/A-
Gain YTD-67.143-63.760105%
P/E RatioN/AN/A-
Revenue7.26KN/A-
Total Cash518KN/A-
Total Debt1.37MN/A-
FUNDAMENTALS RATINGS
SPEV: Fundamental Ratings
SPEV
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPEVUCAR
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SPEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HEPA0.560.04
+7.01%
Hepion Pharmaceuticals
APA20.84-0.21
-1.00%
APA Corp
ATRO16.36-0.24
-1.45%
Astronics Corp
GTX9.18-0.16
-1.71%
Garrett Motion
TOI0.19N/A
-2.00%
Oncology Institute (The)

SPEV and

Correlation & Price change

A.I.dvisor tells us that SPEV and CTNT have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPEV and CTNT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPEV
1D Price
Change %
SPEV100%
N/A
CTNT - SPEV
5%
Poorly correlated
+14.62%
UCAR - SPEV
4%
Poorly correlated
-6.99%
SDA - SPEV
4%
Poorly correlated
-1.58%
NAAS - SPEV
3%
Poorly correlated
+0.50%
PTVLF - SPEV
3%
Poorly correlated
N/A
More

UCAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UCAR has been closely correlated with JZXN. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if UCAR jumps, then JZXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCAR
1D Price
Change %
UCAR100%
-6.99%
JZXN - UCAR
79%
Closely correlated
N/A
CRMT - UCAR
25%
Poorly correlated
-4.80%
CHPT - UCAR
24%
Poorly correlated
N/A
CVNA - UCAR
23%
Poorly correlated
-8.15%
BQ - UCAR
23%
Poorly correlated
-6.86%
More